Dokter Bruno Jansen
ActiveSummary
Dokter Bruno Jansen has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €936k and a net result of €103k. Equity is growing by ~13.2% per year across the filed fiscal years. Its solvency ranks better than 93% of 19908 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
96
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability82▼-1
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €85k at 30 days acceptable
Liquidity ample (current ratio 15.76 against 4.94 in 2023; short-term debt: 2.8% and cash: 37.6% of total assets), and 3.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
96.1%
Return on assets
10.5%
Age of the figures
21 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-08-2025, 29 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
29 d late
2023
90 d late
2022
60 d late
2021
30 d late
2020
2 d early
2019
1 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Turnover
€0
Total assets
€974k▲ 6.9%
2023 · €911k
2018: €788k
2019: €808k
2020: €830k
2021: €833k
2022: €897k
2023: €911k
2018 → 2024
Net result
€103k▼ 2.9%
2023 · €106k
2018: €98k
2019: €80k
2020: €38k
2021: €76k
2022: €85k
2023: €106k
2018 → 2024
Working capital
€408k▲ 36.3%
2023 · €299k
2018: €2k
2019: €82k
2020: €75k
2021: €142k
2022: €207k
2023: €299k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Turnover€0
Equity€566k-€642k▲ 13.4%€728k▲ 13.3%€833k▲ 14.5%€936k▲ 12.3%
Operating result€57k-€109k▲ 91.5%€128k▲ 17.2%€157k▲ 23.4%€151k▼ 3.8%
Net result€38k-€76k▲ 99.3%€85k▲ 12.1%€106k▲ 23.9%€103k▼ 2.9%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 4% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €974k
Fixed assets
€538k ▲ 0.5%
Current assets
€436k ▲ 16.1%
Equity and liabilities €974k
Equity
€936k ▲ 12.3%
Debt
€38k ▼ 50.9%
Debt's share of the balance-sheet total falls from 8.5% to 3.9%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€197k▼
2023 · €202k
Cash flow
€149k▼
2023 · €150k
Current ratio
15.76▲
2023 · 4.94
Debt to equity
0.04▼
2023 · 0.09
ROE
11.0%▼
2023 · 12.7%
ROA
10.5%▼
2023 · 11.6%
Interest coverage
161.92▲
2023 · 142.12
Debt ≤ 1 year
€28k▼
2023 · €76k
Debt > 1 year
€10k▲
2023 · €1k
Income taxes
€49k▼
2023 · €51k
Staff costs
€-5k▼
2023 · €14k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 50 lines
Balance sheet
Code20232024
Assets
Total assets20/58€911k€974k▲
Fixed assets21/28€535k€538k▲
Tangible fixed assets22/27€534k€537k▲
Land and buildings22€508k€504k▼
Plant, machinery and equipment23€3k€9k▲
Furniture and vehicles24€23k€20k▼
Other tangible fixed assets26-€4k
Financial fixed assets28€1k€1k=
Current assets29/58€375k€436k▲
Amounts receivable within one year40/41€50k€69k▲
Trade receivables40€605€2k▲
Other amounts receivable41€50k€68k▲
Cash at bank and in hand54/58€322k€366k▲
Deferred charges and accrued income490/1€3k€558▼
Equity and liabilities
Total equity and liabilities10/49€911k€974k▲
Equity10/15€833k€936k▲
Contributions10/11€19k€19k=
Reserves13€814k€917k▲
Distributable reserves133€814k€917k▲
Profit (loss) carried forward14€226€226=
Amounts payable17/49€77k€38k▼
Amounts payable after more than one year17€1k€10k▲
Financial debts170/4€1k€10k▲
Amounts payable within one year42/48€76k€28k▼
Current portion of amounts payable after more than one year42€50k€13k▼
Trade debts44€7k€2k▼
Suppliers440/4€7k€2k▼
Taxes, remuneration and social security45€17k€12k▼
Taxes450/3€13k€12k▼
Remuneration and social security454/9€5k-
Other amounts payable47/48€929€929=
Accrued charges and deferred income492/3-€262
Income statement
Code20232024
Remuneration, social security and pensions62€14k€-5k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€44k€46k▲
Other operating charges640/8€4k€4k▲
Non-recurring operating charges66A€124-
Gross operating margin9900€220k€197k▼
Operating profit (loss)9901€157k€151k▼
Financial income75/76B€285€1k▲
Recurring financial income75€285€1k▲
Financial charges65/66B€1k€1k▼
Recurring financial charges65€1k€1k▼
Profit (loss) for the period before taxes9903€156k€151k▼
Income taxes67/77€51k€49k▼
Profit (loss) for the period9904€106k€103k▼
Profit (loss) for the period to be appropriated9905€106k€103k▼
Appropriation of the result
Profit (loss) to be appropriated9906€106k€103k▼
Profit (loss) brought forward from the previous period14P€226€226=
Transfer to equity691/2€106k€103k▼
To other reserves6921€106k€103k▼
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
31-12
Financial
Liquidity triplescurrent ratio 15.76
Current ratio from 4.94 to 15.76; short-term debt falls from €76k to €28k.
29-10
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 90 days late
2023
31-12
Financial
Highest result since 2018net €106k ▲23.9%
Operating result €157k, net result €106k, both a record.
29-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 60 days late
2022
30-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 30 days late
2021
29-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Weakest financial yearnet €38k ▼52.4%
Net result drops to €38k, the lowest in the series; recovery starts the following year.
30-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial
Equity above €500kEq €528k ▲17.9%
2 profitable years in a row build equity to €528k.
09-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 9 days late
2018
30-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 30 days late
2017
30-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 30 days late
2016
29-08
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Tienen · 1 establishment unit since 2010
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Kapelstraat 73300 TienenGround area
350 m²
Building footprint
186 m²
Volume, LiDAR
2,009 m³
Parcel 24593H0364/00D000, Flanders · tallest building 15.2 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
DOKTER BRUNO JANSEN BVBA
since 20102.185.273.606
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24593H0364/00D000 | Flanders | 350 m² | 1 · 186 m² | 15.2 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
MEDICE
BE 0821.885.255
Rotselaar · Eq €935,771
Medwest
BE 0832.180.420
Gent · Eq €937,047
Dr. Jan Wynsberghe
BE 0632.654.388
Brugge · Eq €937,644
Dr Petra Van Landeghem, huisarts
BE 0811.611.866
Beveren-Kruibeke-Zwijndrecht · Eq €938,322
MAISON MEDICALE ASASO
BE 0836.790.987
Sint-Gillis (bij-Brussel) · Eq €933,184
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 4,167 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded29-01-2010
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 15 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.